Specialty Pharmacy

05/15/2013 - 11:33am
FDA approves new prostate cancer drug

A new treatment for late-stage prostate cancer has received approval from the Food and Drug Administration.

05/14/2013 - 3:00pm
Teva launches topotecan injection

Teva Health Systems has launched a generic injectable drug for small-cell lung cancer, the company said.

05/14/2013 - 2:40pm
Diplomat Specialty Pharmacy sponsors local adult-fitness event

Diplomat Specialty Pharmacy is among the sponsors of a fundraising effort to expand an adult-fitness program run by a Flint, Mich.-based nonprofit.

05/10/2013 - 4:31pm
SPCB appoints new education director

The Specialty Pharmacy Certification Board has appointed Terri Smith Moore as the education director, the group said.

05/10/2013 - 11:18am
FDA approves Novartis' Ilaris for rare childhood arthritis

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

05/10/2013 - 11:09am
Denovo Biomarkers, ALS-ETF to explore personalized medicine in amyotrophic lateral sclerosis

A biotech company and a non-profit organization are looking into new ways to treat patients with the devastating degenerative disorder commonly known as Lou Gehrig's disease.

05/09/2013 - 2:20pm
Cancer practices hit hard by sequester, study finds

Cuts to Medicare payments due to the budget sequester have hit reimbursements for cancer drugs, according to a nonprofit group.

05/09/2013 - 1:34pm
DEA collects more than 740,000 pounds of unused drugs

The Drug Enforcement Administration collected more than 371 tons of unused medications last month as part of its sixth annual drug take-back program, the agency said.

05/09/2013 - 10:47am
Generic use reached 84% in 2012, study finds

Declining use overall of healthcare services drove down spending on medicines in the United States by 3.5% per capita last year, according to a new study.

05/09/2013 - 8:21am
Senators propose legislation to carve out 'compounding manufacturers' subject to FDA regulation

One of the difficulties that federal regulators ran into during the nationwide scandal surrounding the New England Compounding Center — the Massachusetts-based pharmacy blamed for a nationwide fungal meningitis epidemic that has sickened hundreds and killed dozens — was the issue of when such pharmacies cross the line from compounding to manufacturing.

© 2013 Drug Store News. All Rights Reserved.